 |
| Scientific Medical Board |
|
This distinguished Scientific Medical Board is comprised of
the top experts in cancer research, academics and
education. All major therapeutic and strategic areas of oncology and
hematology are represented on the Board.
The primary mission of this Board is to ensure the highest
quality of specialized oncology training programs for pharmaceutical
industry executives. |
 |
Paul A. Bunn, Jr., MD
Professor of Medicine and
Director
University of Colorado Cancer
Center
Grohne/Stapp Endowed Professor of
Oncology
Executive Director of the International
Association for the Study of Lung Cancer
Denver, Colorado |
 |
Walter J. Curran, Jr., MD
Professor and Chairman,
Department of Radiation Oncology
Clinical Director Kimmel
Cancer Center of Jefferson Medical College
Chairman,
Radiation Therapy Oncology Group
Thomas Jefferson
University Hospital
Philadelphia, Pennsylvania |
 |
Robert B. Diasio, MD
Professor of Pharmacology, Mayo
Clinic College of Medicine
Director, Mayo Clinic Cancer
Center
Rochester, Minnesota |
 |
Roy S. Herbst, MD, Ph.D.
Chief, Section of Thoracic
Oncology Associate Professor of Medicine & Cancer
Biology
Department of Thoracic / Head & Neck Medical
Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas M.D. Anderson Cancer
Center
Houston, Texas |
 |
Peter J. O’Dwyer, MD
Professor of
Medicine
Director, Experimental Therapeutics
Program
Vice Chairman, Eastern Cooperative Oncology
Group
University of Pennsylvania School of
Medicine
Philadelphia, Pennsylvania |
 |
Robert F. Ozols, MD, Ph.D.
Senior Vice President,
Medical Science
Fox Chase Cancer Center
Philadelphia,
Pennsylvania |
 |
Steven T. Rosen, MD, FACP
Genevieve E. Teuton
Professor of Medicine
Director, The Robert H. Lurie
Comprehensive Cancer Center
Northwestern University Medical
School
Chicago, Illinois |
 |
Dennis J. Slamon, MD, Ph.D.
Chief, Division of
Hematology-Oncology
Professor and Executive Vice Chair,
Department of Medicine
Director for Clinical Research
Johnson Comprehensive Cancer Center
Director, Revlon/UCLA
Women’s Health Research and Cancer Research
Programs
University of California at Los Angeles School of
Medicine
Los Angeles, California |
 |
Nicholas J. Vogelzang, MD
Director, Cancer Research
Center
Nevada Cancer Institute
Las Vegas, NV |
 |
Connie Henke Yarbro, MS, RN, FAAN
Editor, Seminars
in Oncology Nursing
Clinical Associate Professor
Division of Hematology and Oncology,
University of
Missouri-Columbia Adjunct
Clinical Associate Professor
Sinclair School of Nursing
Columbia, Missouri |
|
|
A division of Oncology Learning Center
© 2010 Curbside CME • 1415 Legacy Dr., Suite 250 • Frisco, TX 75034 • Phone: 214-269-2014 |
| Disclaimer: The material published on the Curbside CME Web site reflect the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the Curbside CME, the CME provider, or the pharmaceutical companies providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified medical or surgical oncologist, or hematologist should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any Curbside CME materials. |
|
